120 related articles for article (PubMed ID: 3315451)
1. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension.
Balazovjech I; Skultétyová D; Mikulecký M; Kratochvíl'ová H
Cor Vasa; 1987; 29(4 Suppl 1):46-52. PubMed ID: 3315451
[TBL] [Abstract][Full Text] [Related]
2. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
Mayer O; Polívková H
Cor Vasa; 1987; 29(4 Suppl 1):37-41. PubMed ID: 3315449
[TBL] [Abstract][Full Text] [Related]
3. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
Bazika V
Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450
[TBL] [Abstract][Full Text] [Related]
4. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
Dvorák I; Podrouzková B; Kocourková J; Kubesová H; Spác J; Nĕmcová H; Blaha M
Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
[TBL] [Abstract][Full Text] [Related]
5. [Minimal useful dose of guanfacine in patients with essential hypertension].
Pérez Olea J; Ortíz N; Soledad Bertoló M; Allel L; Goity C; Quevedo M
Rev Med Chil; 1985 May; 113(5):420-4. PubMed ID: 3912882
[No Abstract] [Full Text] [Related]
6. [Circadian changes in arterial blood pressure and hemodynamics and the morphofunctional state of the myocardium in patients with hypertension during long-term treatment with estulic].
Komarov FI; Ol'binskaia LI; Iamshchikov SN
Klin Med (Mosk); 1990 Feb; 68(2):58-61. PubMed ID: 2186218
[TBL] [Abstract][Full Text] [Related]
7. [Effect of long-term treatment with guanfacine on selected humoral metabolic indices in patients with primary hypertension].
Knypl K; Wocial B; Chodakowska J; Brym E; Czerniewska E; Wacławek-Maczkowska J; Kuczyńska K; Berent H; Januszewicz W
Pol Tyg Lek; 1989 Mar 20-27; 44(12-13):293-6. PubMed ID: 2530502
[TBL] [Abstract][Full Text] [Related]
8. [Estulic in the long-term treatment of hypertension].
Rhomberg F
Schweiz Med Wochenschr; 1980 Dec; 110(50):1922-4. PubMed ID: 6782668
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of arterial hypertension with a single daily dose of guanfacine].
Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
[No Abstract] [Full Text] [Related]
10. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
[No Abstract] [Full Text] [Related]
11. Prolactin, renin, growth hormone, lipoproteins and glucose under guanfacine treatment.
Hauger-Klevene JH; Balossi EC; Scornavacchi JC
Cor Vasa; 1987; 29(4 Suppl 1):17-22. PubMed ID: 3119290
[TBL] [Abstract][Full Text] [Related]
12. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
13. [Effect of guanfacine on arterial blood pressure and serum lipids and lipoproteins].
Sznajderman M; Niegowska J; Sznajderman M
Pol Tyg Lek; 1987 Dec 21-28; 42(51-52):1637-41. PubMed ID: 3330797
[No Abstract] [Full Text] [Related]
14. [Labetalol and guanfacine in the treatment of arterial hypertension in patients with chronic renal failure].
Lifshits NL; Ermolenko VM; Rozhdestvenskaia TM; Tatsievskiĭ VA; Panasiuk VV
Ter Arkh; 1984; 56(7):66-9. PubMed ID: 6385325
[No Abstract] [Full Text] [Related]
15. [Antihypertensive therapy with guanfacine. A multicenter trial with Estulic Wander 1 mg].
Schäfer N; Knaup G
MMW Munch Med Wochenschr; 1982 Mar; 124(10):249-52. PubMed ID: 6806612
[No Abstract] [Full Text] [Related]
16. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
Schäfer N; Knaup G
Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
[No Abstract] [Full Text] [Related]
17. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO].
Mayer K; Lupínek Z; Janousek S; Podrouzková B
Cas Lek Cesk; 1984 Oct; 123(43):1306-11. PubMed ID: 6391673
[No Abstract] [Full Text] [Related]
18. [Use of estulic in patients with arterial hypertension].
Kukes VG; Spasskiĭ AV; Alkhazov AI; Rudakov AG; Zisel'man SB
Sov Med; 1985; (12):57-61. PubMed ID: 3913006
[No Abstract] [Full Text] [Related]
19. Use of tensiomin (captopril) in the antihypertensive treatment of haemodialysis patients.
Kakuk G; Kurta G; Kárpáti I; Mátyus J
Ther Hung; 1990; 38(2):71-6. PubMed ID: 2198678
[TBL] [Abstract][Full Text] [Related]
20. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
Jerie P; Lasance A
Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):279-87. PubMed ID: 7030975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
